LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset (ID:20238)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

<
<<
Previous
Page 1 of 483
Next
>>
>
1 to 25 of 12072 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
Hs 578T	AZD 5438	0.04	uM	LJP6	3	J06	72	hr	765	2877	3124	0.9208	0.8951
Hs 578T	AZD8055	0.04	uM	LJP6	2	A12	72	hr	765	1093	3124	0.3498	0.1390
Hs 578T	Alvocidib	0.04	uM	LJP6	1	A18	72	hr	765	1839	3124	0.5886	0.4552
Hs 578T	AZD 5438	0.04	uM	LJP6	2	J06	72	hr	765	2858	3124	0.9147	0.8870
Hs 578T	AZD7762	0.04	uM	LJP6	1	L06	72	hr	765	1179	3124	0.3773	0.1754
Hs 578T	AZD8055	0.04	uM	LJP6	1	A12	72	hr	765	1134	3124	0.3629	0.1564
Hs 578T	Afatinib	0.04	uM	LJP6	3	G24	72	hr	765	2902	3124	0.9288	0.9057
Hs 578T	Sigma A6730	0.04	uM	LJP5	3	B24	72	hr	765	3058	3124	0.9787	0.9718
Hs 578T	AT-7519	0.04	uM	LJP6	1	K06	72	hr	765	2651	3124	0.8485	0.7993
Hs 578T	AZD 5438	0.04	uM	LJP6	1	J06	72	hr	765	3076	3124	0.9845	0.9794
Hs 578T	AZD-6482	0.04	uM	LJP5	2	I06	72	hr	765	2802	3124	0.8968	0.8633
Hs 578T	AZD-6482	0.04	uM	LJP5	3	I06	72	hr	765	2827	3124	0.9048	0.8739
Hs 578T	AZD7762	0.04	uM	LJP6	2	L06	72	hr	765	1036	3124	0.3316	0.1148
Hs 578T	AZD7762	0.04	uM	LJP6	3	L06	72	hr	765	1135	3124	0.3633	0.1568
Hs 578T	Afatinib	0.04	uM	LJP6	1	G24	72	hr	765	3036	3124	0.9717	0.9625
Hs 578T	Afatinib	0.04	uM	LJP6	2	G24	72	hr	765	2861	3124	0.9157	0.8883
Hs 578T	Sigma A6730	0.04	uM	LJP5	1	B24	72	hr	765	3107	3124	0.9944	0.9926
Hs 578T	Sigma A6730	0.04	uM	LJP5	2	B24	72	hr	765	3073	3124	0.9835	0.9782
Hs 578T	Alvocidib	0.04	uM	LJP6	2	A18	72	hr	765	2018	3124	0.6459	0.5310
Hs 578T	Alvocidib	0.04	uM	LJP6	3	A18	72	hr	765	1953	3124	0.6251	0.5035
Hs 578T	AT-7519	0.04	uM	LJP6	2	K06	72	hr	765	2915	3124	0.9329	0.9112
Hs 578T	AT-7519	0.04	uM	LJP6	3	K06	72	hr	765	2983	3124	0.9547	0.9400
Hs 578T	AZD-6482	0.04	uM	LJP5	1	I06	72	hr	765	2834	3124	0.9070	0.8769
Hs 578T	AZD8330	0.04	uM	LJP5	1	G24	72	hr	765	1064	3124	0.3405	0.1267
Hs 578T	AZD8055	0.04	uM	LJP6	3	A12	72	hr	765	1138	3124	0.3642	0.1581

<
<<
Previous
Page 1 of 483
Next
>>
>
1 to 25 of 12072 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset (ID:20238)